Literature DB >> 304908

Activation of electrogenic Na+ pump by epinephrine in bullfrog atrium.

T Akasu, Y Ohta, K Koketsu.   

Abstract

The effects of epinephrine (1 X 10(-6)--1 X 10(-5) M) on the resting membrane potential and the K+-activated hyperpolarization of bullfrog atrial heart muscles were studied by the single sucrose-gap method or by intracellular microelectrode filled with 3 M KC1. Epinephrine-induced hyperpolarization (Ep-hyperpolarization) was completely eliminated by the effect of ouabain or by removal of extracellular K+. The amplitude of K+-activated hyperpolarization, which was produced when the extracellular K+ concentration was raised from zero to 2 mM, was markedly increased in the presence of epinephrine. The membrane depolarizations, due to high extracellular K+ concentration in the presence of ouabain (5 X 10(-6) M) which completely and reversibly eliminated the K+-activated hyperpolarization, were not altered under the effect of epinephrine. These results suggested that Ep-hyperpolarization of bullfrog atrial heart muscles was due to the acceleration of electrogenic Na+ pump which produced the K+-activated hyperpolarization.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 304908     DOI: 10.1536/ihj.18.860

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

1.  The effect of adrenaline on the electrogenic Na+ pump in cardiac muscle cells.

Authors:  T Akasu; Y Ohta; K Koketsu
Journal:  Experientia       Date:  1978-04-15

2.  Noradrenaline hyperpolarizes cells of the canine coronary sinus by increasing their permeability to potassium ions.

Authors:  P A Boyden; P F Cranefield; D C Gadsby
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

3.  Effects of Ca2+ channel antagonists and ryanodine on H1-receptor mediated electromechanical response to histamine in guinea-pig left atria.

Authors:  Y Hattori; H Nakaya; N Tohse; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.